Related references
Note: Only part of the references are listed.DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
Ssu-Chuan Lai et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
TGF-β-induced alternative splicing of TAK1 promotes EMT and drug resistance
Veenu Tripathi et al.
ONCOGENE (2019)
Current and future therapeutic approaches for osteosarcoma
Douglas J. Harrison et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma
Xiao-Mei Gao et al.
ONCOTARGETS AND THERAPY (2018)
miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1
Jianyong Liu et al.
ONCOLOGY LETTERS (2018)
Long non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis of osteosarcoma by targeting ROCK1
Zhiwen Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Molecular pathways involved in microRNA-mediated regulation of multidrug resistance
Rongrong Liao et al.
MOLECULAR BIOLOGY REPORTS (2018)
miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo
Zhenfeng Duan et al.
MOLECULAR ONCOLOGY (2017)
Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia
Stefanie Goellner et al.
NATURE MEDICINE (2017)
MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1
J. Lu et al.
ONCOGENE (2017)
Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer
Prashant Joshi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene
Youguang Pu et al.
SCIENTIFIC REPORTS (2017)
Regulation of multidrug resistance by microRNAs in anti-cancer therapy
Xin An et al.
ACTA PHARMACEUTICA SINICA B (2017)
MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy
Yichen Meng et al.
SCIENTIFIC REPORTS (2017)
Phosphoproteomics Reveals HMGA1, a CK2 Substrate, as a Drug-Resistant Target in Non-Small Cell Lung Cancer
Yi-Ting Wang et al.
SCIENTIFIC REPORTS (2017)
MiR-20a-5p represses the multi-drug resistance of osteosarcoma by targeting the SDC2 gene
Fangfang Zhao et al.
CANCER CELL INTERNATIONAL (2017)
Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer
Yong Yang et al.
CANCER BIOLOGY & THERAPY (2016)
Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression
Yan Zhou et al.
ACTA PHARMACOLOGICA SINICA (2016)
Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells
Dae Kyoung Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Advances in emerging drugs for osteosarcoma
Claudia Maria Hattinger et al.
EXPERT OPINION ON EMERGING DRUGS (2015)
Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1
Yangyang Ou et al.
GENE (2015)
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
Michael S. Isakoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
MITF Modulates Therapeutic Resistance through EGFR Signaling
Zhenyu Ji et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Clinical efficacy of preoperative chemotherapy with or without ifosfamide in patients with osteosarcoma of the extremity: meta-analysis of randomized controlled trials
Wenmei Su et al.
MEDICAL ONCOLOGY (2015)
Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal
Suoyuan Li et al.
TUMOR BIOLOGY (2015)
MicroRNAs and potential targets in osteosarcoma: review
Valerie B. Sampson et al.
FRONTIERS IN PEDIATRICS (2015)
MicroRNAs in Cancer
Gianpiero Di Leva et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Osteosarcoma treatment - Where do we stand? A state of the art review
Anja Luetke et al.
CANCER TREATMENT REVIEWS (2014)
BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer
Asuka Sugio et al.
GYNECOLOGIC ONCOLOGY (2014)
Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients
Qi-Chun Song et al.
ONCOLOGY REPORTS (2014)
MicroRNAs in cancer: biomarkers, functions and therapy
Josie Hayes et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers
P. E. Lonning et al.
ONCOGENE (2013)
Overexpression of Mcl-1 Confers Multidrug Resistance, Whereas Topoisomerase IIβ Downregulation Introduces Mitoxantrone-Specific Drug Resistance in Acute Myeloid Leukemia
David L. Hermanson et al.
MOLECULAR PHARMACOLOGY (2013)
MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN
Boning Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer
M. P. H. M. Jansen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2
Juan Lu et al.
CANCER RESEARCH (2011)
Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
Amit K. Tiwari et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45 alpha expression
Cao Yang et al.
APOPTOSIS (2009)
Current Status and Perspectives Regarding the Treatment of Osteosarcoma: Chemotherapy
Akio Sakamoto et al.
REVIEWS ON RECENT CLINICAL TRIALS (2008)
Osteosarcoma (Osteogenic sarcoma)
Piero Picci
ORPHANET JOURNAL OF RARE DISEASES (2007)
The role of glutathione-S-transferase in anti-cancer drug resistance
DM Townsend et al.
ONCOGENE (2003)
Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity - Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor
G Bacci et al.
CANCER (2003)
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms
AA Sandberg et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
